{
    "clinical_study": {
        "@rank": "33546", 
        "arm_group": {
            "arm_group_label": "Adult Group", 
            "arm_group_type": "Other", 
            "description": "Not Applicable."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to perform a epidemiological survey of the adult population in\n      Hungary to calculate the seroprevalence of pertussis."
        }, 
        "brief_title": "A Study to Determine the Seroprevalence of Bordetella Pertussis in Adults in Hungary", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Pertussis", 
        "condition_browse": {
            "mesh_term": "Whooping Cough"
        }, 
        "detailed_description": {
            "textblock": "The protocol posting was amended to correct the detailed title. Since a sample of blood will\n      be collected from all subjects (outside of routine hospital procedure), the study does not\n      meet GSK's definition of an observational study and hence the term \"observational\" was\n      deleted from the detailed title."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects who the investigator believes can and will comply with the requirements of\n             the protocol.\n\n          -  Written informed consent will be obtained from subjects prior to performing any study\n             procedures.\n\n          -  Males or females \u2265 18 years of age at the time of enrollment.\n\n          -  Agreeing to collection of a blood sample for the study.\n\n        Exclusion Criteria:\n\n        \u2022  Confirmed or suspected immunological disorder."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "2000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02014519", 
            "org_study_id": "116804"
        }, 
        "intervention": [
            {
                "arm_group_label": "Adult Group", 
                "description": "A blood sample (2.5 mL) will be collected from all subjects", 
                "intervention_name": "Blood sampling", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Adult Group", 
                "description": "Active questioning", 
                "intervention_name": "Data collection", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Adults", 
            "Hungary", 
            "Bordetella pertussis", 
            "Seroprevalence", 
            "Pertussis antibodies"
        ], 
        "lastchanged_date": "May 8, 2014", 
        "location": [
            {
                "contact": {
                    "email": "GSKClinicalSupportHD@gsk.com", 
                    "last_name": "US GSK Clinical Trials Call Center", 
                    "phone": "877-379-3718"
                }, 
                "contact_backup": {
                    "email": "GSKClinicalSupportHD@gsk.com", 
                    "last_name": "EU GSK Clinical Trials Call Center", 
                    "phone": "+44 (0) 20 8990 4466"
                }, 
                "facility": {
                    "address": {
                        "city": "Kecskem\u00e9t", 
                        "country": "Hungary", 
                        "zip": "6000"
                    }, 
                    "name": "GSK Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "GSKClinicalSupportHD@gsk.com", 
                    "last_name": "US GSK Clinical Trials Call Center", 
                    "phone": "877-379-3718"
                }, 
                "contact_backup": {
                    "email": "GSKClinicalSupportHD@gsk.com", 
                    "last_name": "EU GSK Clinical Trials Call Center", 
                    "phone": "+44 (0) 20 8990 4466"
                }, 
                "facility": {
                    "address": {
                        "city": "Zirc", 
                        "country": "Hungary", 
                        "zip": "8420"
                    }, 
                    "name": "GSK Investigational Site"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Hungary"
        }, 
        "number_of_arms": "1", 
        "official_title": "Seroprevalence of Bordetella Pertussis in Adults in Hungary", 
        "overall_contact": {
            "email": "GSKClinicalSupportHD@gsk.com", 
            "last_name": "US GSK Clinical Trials Call Center", 
            "phone": "877-379-3718"
        }, 
        "overall_official": {
            "affiliation": "GlaxoSmithKline", 
            "last_name": "GSK Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Hungary: Human Resources Ministry"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Seroprevalence of Bordetella pertussis antibodies among adults aged 18 years and above with respect to anti- Pertussis Toxin (PT) antibody levels, anti-PT seropositivity status and anti-PT seronegativity status.", 
            "safety_issue": "No", 
            "time_frame": "At the time of enrollment of each subject (Day 0)."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02014519"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Seroprevalence of Bordetella pertussis antibodies in individual age-groups (18-29 years, 30-44 years, 45-59 years and \u2265 60 years) with respect to anti-PT antibody levels, anti-PT seropositivity status and anti-PT seronegativity status.", 
                "safety_issue": "No", 
                "time_frame": "At the time of enrollment of each subject (Day 0)."
            }, 
            {
                "description": "By gender; By recent history of long-lasting cough; By smoking status; By history of pertussis; By history of vaccination against pertussis; By medication and hospitalisation due to respiratory infections in the previous 12 months.", 
                "measure": "Seroprevalence of Bordetella pertussis antibodies in adults aged 18 years and above with respect to anti-PT antibody levels suggesting recent infection and anti-PT antibody levels not suggesting recent infection.", 
                "safety_issue": "No", 
                "time_frame": "At the time of enrollment of each subject (Day 0)."
            }
        ], 
        "source": "GlaxoSmithKline", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "GlaxoSmithKline", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}